RCUS
Arcus Biosciences
$27.84
−$0.58 (−2.04%)Jul 27, 2026
Key metrics
The numbers that frame RCUS today
- Market cap
- $3.50B
- P/E (TTM)
- -9.5
- EV / FCF
- -7.0
- Gross margin
- 100%
- EV / Sales
- 14.4
- ROIC
- -51.6%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $8.84
- 52wk High
- $31.74
Growth
Revenue and earnings trend for RCUS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RCUS
Is Arcus Biosciences a good buy?
Yes. Arcus Biosciences has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks poor, a caveat that does not overturn the setup. We think Arcus Biosciences is selling at a very high price, which cuts against the buy case.
What is the market capitalization of RCUS?
Arcus Biosciences's market capitalization is $3.50B.
What is the P/E ratio for RCUS stock?
Arcus Biosciences's current P/E ratio is -9.5.
What is the 52-week high for RCUS stock?
The 52-week high for Arcus Biosciences is $31.74. The current close of $27.84 is 12.3% below that high.
What is the 52-week low for RCUS stock?
The 52-week low for Arcus Biosciences is $8.84. The current close of $27.84 is 214.9% above that low.
Does RCUS stock pay dividends?
Arcus Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RCUS?
Arcus Biosciences's Debt / Equity ratio is 0.19.